Disc Medicine, Inc. - Common Stock, par value $0.0001 per share (IRON)

CUSIP: 254604101

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
+861,706
Put/Call ratio
114%
SEC-reported price per share
$46.98
Number of holders
90
Value change
+$42,877,645
Number of buys
57
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,597,121

Security key

254604101

Report period

Q3 2023

Institutions

90

Top holders

10

Ownership snapshot

Top reported holders of IRON - Disc Medicine, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Braden M. Leonard
Disclosed value leader
Braden M. Leonard
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5 13F Highest disclosed value: $354,993,375 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Braden M. Leonard has the largest disclosed position value at $354.99M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Braden M. Leonard's linked filing trail.
Disclosed position value Top 5
Braden M. Leonard $354.99M
Novo Holdings A/S $73.79M
James B. Tananbaum $27.84M
Atlas Venture Opportunity Fund II... $14.77M
Atlas Venture Life Science Adviso... $153.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Braden M. Leonard
3/4/5
10%+ Owner
—
denominator unverified
$354,993,375
5,247,500 shares
— 26 Oct 2022
Novo Holdings A/S
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$73,790,726
1,090,772 shares
— 28 Jun 2023
James B. Tananbaum
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$27,837,975
428,745 shares
mixed-class rows
— 04 Oct 2021
Atlas Venture Opportunity Fund II, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$14,769,754
218,326 shares
— 29 Dec 2022
Carl L. Gordon
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
17,245 shares
— 04 Oct 2021
Jason P. Rhodes
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
17,245 shares
— 04 Oct 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
19,879,838
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
89
Q3 2023 holders
90
Holder diff
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .